128 related articles for article (PubMed ID: 10702341)
1. A simple and rapid evaluation of methemoglobin toxicity of 8-aminoquinolines and related compounds.
Srivastava P; Singh S; Jain GK; Puri SK; Pandey VC
Ecotoxicol Environ Saf; 2000 Mar; 45(3):236-9. PubMed ID: 10702341
[TBL] [Abstract][Full Text] [Related]
2. Methemoglobin reductase activity and in vitro sensitivity towards oxidant induced methemoglobinemia in swiss mice and beagle dogs erythrocytes.
Srivastava S; Alhomida AS; Siddiqi NJ; Puri SK; Pandey VC
Mol Cell Biochem; 2002 Mar; 232(1-2):81-5. PubMed ID: 12030383
[TBL] [Abstract][Full Text] [Related]
3. Methemoglobin toxicity and hematological studies on malaria anti-relapse compound CDRI 80/53 in dogs.
Puri SK; Srivastava R; Pandey VC; Sethi N; Dutta GP
Am J Trop Med Hyg; 1989 Dec; 41(6):638-42. PubMed ID: 2641641
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates.
Link CM; Theoharides AD; Anders JC; Chung H; Canfield CJ
Toxicol Appl Pharmacol; 1985 Nov; 81(2):192-202. PubMed ID: 4060148
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of bisquinolines and their in vitro ability to produce methemoglobin in canine hemolysate.
Srivastava S; Tewari S; Chauhan PM; Puri SK; Bhaduri AP; Pandey VC
Bioorg Med Chem Lett; 1999 Mar; 9(5):653-8. PubMed ID: 10201823
[TBL] [Abstract][Full Text] [Related]
6. Methemoglobin formation resulting from administration of candidate 8-aminoquinoline antiparasitic drugs in the dog.
Anders JC; Chung H; Theoharides AD
Fundam Appl Toxicol; 1988 Feb; 10(2):270-5. PubMed ID: 3356313
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
8. An improved pharmacodynamic model for formation of methemoglobin by antimalarial drugs.
Fasanmade AA; Jusko WJ
Drug Metab Dispos; 1995 May; 23(5):573-6. PubMed ID: 7587933
[TBL] [Abstract][Full Text] [Related]
9. New tissue schizontocidal antimalarial drugs.
Davidson DE; Ager AL; Brown JL; Chapple FE; Whitmire RE; Rossan RN
Bull World Health Organ; 1981; 59(3):463-79. PubMed ID: 6976854
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and methemoglobin toxicity of the amides of 6/7 mono or disubstituted quinolone.
Srivastava S; Srivastava SK; Shukla A; Chauhan PM; Puri SK; Bhaduri AP; Pandey VC
Bioorg Med Chem Lett; 1999 Jan; 9(1):25-30. PubMed ID: 9990450
[TBL] [Abstract][Full Text] [Related]
12. Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to
Vieira JL; Ferreira MES; Ferreira MVD; Gomes MM
Am J Trop Med Hyg; 2017 May; 96(5):1171-1175. PubMed ID: 28440745
[TBL] [Abstract][Full Text] [Related]
13. Changes in rodent-erythrocyte methemoglobin reductase system produced by two malaria parasites, viz. Plasmodium yoelii nigeriensis and Plasmodium berghei.
Srivastava S; Alhomida AS; Siddiqi NJ; Pandey VC
Comp Biochem Physiol B Biochem Mol Biol; 2001 Jul; 129(4):725-31. PubMed ID: 11435127
[TBL] [Abstract][Full Text] [Related]
14. Toxicity in rhesus monkeys following administration of the 8-aminoquinoline 8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline (WR242511).
Rockwood G; Duniho S; Briscoe C; Gold M; Armstrong K; Kahler D; Moran A; Baskin S
J Med Toxicol; 2008 Sep; 4(3):157-66. PubMed ID: 18821488
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.
Fletcher KA; Barton PF; Kelly JA
Biochem Pharmacol; 1988 Jul; 37(13):2683-90. PubMed ID: 2839199
[TBL] [Abstract][Full Text] [Related]
16. Peroxidation of the antimalarial drug primaquine: characterization of a benzidine-like metabolite with methaemoglobin-forming activity.
Morais Mda S; Augusto O
Xenobiotica; 1993 Feb; 23(2):133-9. PubMed ID: 8498077
[TBL] [Abstract][Full Text] [Related]
17. Interspecies variability in propylene glycol dinitrate-induced methemoglobin formation.
Wyman JF; Gray BH; Lee LH; Coleman J; Flemming C; Uddin DE
Toxicol Appl Pharmacol; 1985 Nov; 81(2):203-12. PubMed ID: 4060149
[TBL] [Abstract][Full Text] [Related]
18. Effect of beta-arteether treatment on erythrocytic methemoglobin reductase system in Plasmodium yoelii nigeriensis infected mice.
Srivastava S; Alhomida AS; Siddiqi NJ; Pandey VC; Puri SK
Drug Chem Toxicol; 2001 May; 24(2):181-90. PubMed ID: 11360434
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
20. Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man.
Carson PE; Hohl R; Nora MV; Parkhurst GW; Ahmad T; Scanlan S; Frischer H
Bull World Health Organ; 1981; 59(3):427-37. PubMed ID: 6976850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
